Lack Of Incentives Threatens AMR Investment

Over A Third Of AMRIA Members Have Said They Could Cut AMR Spending

 
• By Chloe Kent
  
Antimicrobial susceptibility resistance diffusion test
AMRIA members contributed to R&D on 93 AMR products and technologies • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products